March 6, 2021 10:14 PM
Latest:
  • Toronto Home Sales Surge to Highest on Record for February
  • Canada Nickel Company: Strong Nickel Demand Underscores The Value Of Its Properties
  • Gold Feeling Like It’s At A Low – The Daily Dive feat Greg Johnson
  • Canada’s Trade Surplus Exceeds Pre-Pandemic Levels, Rises to $1.4 Billion in January
  • Air Canada: BMO Reinstates Coverage With $33 Price Target
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Cannabis
      • Pure Extracts
      • Tinley Beverage Co
    • Mining
      • AUX Resources
      • Freeman Gold
      • Newlox Gold Ventures
      • Noram Ventures
      • Riverside Resources
      • SKRR Exploration Inc.
      • Spruce Ridge Resources
    • Technology
      • CloudMD
      • Datametrex AI Limited
      • MustGrow Biologics
      • PowerBand Solutions
      • Revive Therapeutics
  • Resources
  • About
  • Contact Us
  • Advertise With Us

MindMed

Briefing Psychedelics Technology 

MindMed Acquires HealthMode For $41.6 Million

February 18, 2021 8:21 AMFebruary 18, 2021 8:21 AM Jay Lutz 0 Comments Mind Medicine, MindMed

MindMed (NEO: MMED) this morning announced that it will be acquiring that of HealthMode in a largely stock-based transaction. HealthMode

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Begins Study On LSD Neutralizer Technology

February 17, 2021 8:18 AMFebruary 17, 2021 8:19 AM Jay Lutz 0 Comments Mind Medicine, MindMed

MindMed (NEO: MMED) this morning announced that it has begun a study on what it refers to as “LSD neutralizer

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Launches Clinical Trial Focused On Combining LSD With MDMA

January 20, 2021 8:09 AMJanuary 20, 2021 8:10 AM Jay Lutz 1 Comment Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has begun the first clinical trials focused on combining MDMA and LSD. The trials, to be

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Raises $92.1 Million Via Bought Deal Financing

January 7, 2021 9:31 AMJanuary 7, 2021 9:32 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has closed its previously announced bought deal financing, raising nearly double the initial $50.0 million the

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Closes $34.5 Million Financing, Cash Reserves Said To Be At $85 Million

December 11, 2020 9:15 AMDecember 11, 2020 9:15 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has completed its previously announced bought deal private placement, raising gross proceeds of $34.5 million. The

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Returns To Trough For Further $25.0 Million

November 25, 2020 9:25 AMNovember 25, 2020 9:25 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) continues to take investor dollars, this morning announcing a bought deal private placement for $25.0 million.

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine: Canaccord Maintains Ratings Following Financial Results

November 17, 2020 10:17 AMNovember 17, 2020 10:02 AM Justin Young 0 Comments Analyst Estimate, Mind Medicine, MindMed

On Friday, November 13th, Mind Medicine (NEO: MMED) reported their third quarter 2020 financial results. Tania Gonsalves, Canaccord Genuity’s biotechnology

Share
Tweet
Share
Read more
Briefing Psychedelics 

Canaccord Raises Mind Medicine’s Price Target To $2.00 Following Financing

November 2, 2020 10:45 AMNovember 2, 2020 10:50 AM Justin Young 2 Comments Analyst Estimate, Mind Medicine, MindMed

This morning, Canaccord Genuity raised its 12-month price target on Mind Medicine (NEO: MMED) from C$1.75 to C$2.00 while reiterating

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine: Canaccord Genuity Initiates Coverage With C$1.75 Price Target

September 16, 2020 4:15 PMSeptember 16, 2020 3:16 PM Justin Young 0 Comments Analyst Estimate, Mind Medicine, MindMed

Yesterday, Canaccord initiated coverage on Mind Medicine (NEO: MMED) with a Speculative Buy rating and a C$1.75 price target. Canaccord’s

Share
Tweet
Share
Read more
Briefing Psychedelics 

MindMed Adds MDMA To R&D Pipeline

May 27, 2020 9:00 AMMay 27, 2020 9:00 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine, also known as MindMed (NEO: MMED) this morning announced that it is branching out its research and development

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Toronto Home Sales Surge to Highest on Record for February
Briefing Macro 

Toronto Home Sales Surge to Highest on Record for February

March 6, 2021 4:22 PM Hermina Paull 0

Canada’s largest housing market had another historic month in February, as home sales in the Greater Toronto Area soared by

Canada Nickel Company: Strong Nickel Demand Underscores The Value Of Its Properties
Briefing Full Analysis Resources 

Canada Nickel Company: Strong Nickel Demand Underscores The Value Of Its Properties

March 6, 2021 2:45 PM Jim McFadden 0
Gold Feeling Like It’s At A Low – The Daily Dive feat Greg Johnson
Briefing Resources Video Series 

Gold Feeling Like It’s At A Low – The Daily Dive feat Greg Johnson

March 6, 2021 1:30 PM Jay Lutz 0
Canada’s Trade Surplus Exceeds Pre-Pandemic Levels, Rises to $1.4 Billion in January
Briefing Macro 

Canada’s Trade Surplus Exceeds Pre-Pandemic Levels, Rises to $1.4 Billion in January

March 6, 2021 11:31 AM Hermina Paull 0
Air Canada: BMO Reinstates Coverage With $33 Price Target
Automotive Briefing 

Air Canada: BMO Reinstates Coverage With $33 Price Target

March 6, 2021 10:17 AM Justin Young 0
US Cannabis: The Current Landscape
Briefing Cannabis Full Analysis Video Series 

US Cannabis: The Current Landscape

March 6, 2021 9:00 AM Jay Lutz 0
US Unemployment Rate Falls to 6.2%, Pushing 10-Year Treasuries to New Highs
Bonds Briefing Macro 

US Unemployment Rate Falls to 6.2%, Pushing 10-Year Treasuries to New Highs

March 5, 2021 4:01 PM Hermina Paull 0

Spotlight Series

Gold Feeling Like It’s At A Low – The Daily Dive feat Greg Johnson
Briefing Resources Video Series 

Gold Feeling Like It’s At A Low – The Daily Dive feat Greg Johnson

March 6, 2021 1:30 PM Jay Lutz 0

On the Saturday edition of the Daily Dive, our host Cassandra Leah sits down with the CEO and Chairman of

News

DigiMax Provides Progress Update For CryptoDivine
Blockchain Briefing News 

DigiMax Provides Progress Update For CryptoDivine

March 5, 2021 8:38 AM Jay Lutz 0

DigiMax Global Solutions (CSE: DIGI) this morning provided an update for its Crypto Price Trend Indicator App. The firm reported

Pure Extracts Applies For Dealers License With Health Canada
Briefing News Psychedelics 

Pure Extracts Applies For Dealers License With Health Canada

March 4, 2021 7:13 AM Jay Lutz 0
Relay Medical Acquires Cybersecurity Firm Cybeats Technology
Briefing News Technology 

Relay Medical Acquires Cybersecurity Firm Cybeats Technology

March 3, 2021 4:49 PM Jay Lutz 0
Exploits Discovery Announces 4,500 Metre Drill Program For Dog Bay Property
Briefing News Resources 

Exploits Discovery Announces 4,500 Metre Drill Program For Dog Bay Property

March 3, 2021 9:24 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Need some freelance work done? We’re experienced in many forms of writing, including press releases. Shoot us an email & let’s chat!

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Psychedelics
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2021 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.